Advertisement
Screener

HealthLynked Corp. (HLYK) Sale of Stock, Consideration Received Per Transaction

HealthLynked Corp. Sale of Stock, Consideration Received Per Transaction

HealthLynked Corp. (HLYK) reported Sale of Stock, Consideration Received Per Transaction of $1.46 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.

Discontinued › Notes › Equity

us-gaap:SaleOfStockConsiderationReceivedPerTransaction · last filed 2024-05-15

  • HealthLynked Corp. sale of stock, consideration received per transaction for the quarter ending 2024-03-31 was $1.46M.
  • HealthLynked Corp. sale of stock, consideration received per transaction for the quarter ending 2023-12-31 was $0.00.
  • HealthLynked Corp. sale of stock, consideration received per transaction for fiscal 2023 was $1.46M.
Period endSale of Stock, Consideration Received Per Transaction 3 monthSale of Stock, Consideration Received Per Transaction 6 monthSale of Stock, Consideration Received Per Transaction 9 monthSale of Stock, Consideration Received Per Transaction 12 month
2024-03-31$1.46M
10-Q · filed 2024-05-15
$1.46M
derived: sum of 2 quarters · filed 2024-05-15
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$1.46M
10-K · filed 2024-04-01
2023-09-30$1.46M
10-Q · filed 2023-11-14